6 May 2023
Toxins Webinar | Fungal Metabolites: From Toxins to Therapeutics, Held on 12 May 2023
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
On 12 May 2023, MDPI and the journal Toxins (ISSN: 2072-6651) organized a webinar of the Toxins series, titled “Fungal Metabolites: From Toxins to Therapeutics”. The webinar focused on the study of mycotoxins. Mycotoxins are secondary metabolites produced by various filamentous fungi infecting plants and crops. It is now known that mycotoxins, through their biological activities, play crucial roles in fungi biology and ecology. Mycotoxins also have consequences for animal and human health through the ingestion of contaminated food and feeds, with animals/humans in that case being collateral casualties and not primary targets.
Dr. Marc Maresca and Dr. Isabelle Oswald gave an opening introduction first. Then, Prof. Sarah De Saeger introduced the mycotoxin bioanalysis: from human biomonitoring towards exposomics. Dr. Carine Al Ayoubi developed the evaluation of the mutagenicity and metabolism of the emerging mycotoxin versicolorin A, a precursor of aflatoxin B1. Dr. Hamza Olleik talked about whether fungal cyclo-depsipeptides are toxic or therapeutic. Lastly, Dr. Ana Olívia De Souza presented fungi from Brazilian biodiversity as a source of bioactive secondary metabolites.
Please note that this webinar is associated with a Topic in the Toxins journal: “Editorial Board Members’ Collection Series: Fungal Metabolites: From Toxins to Therapeutics”.
You can watch the recorded webinar at the following link: https://youtu.be/6PkHxGxDOds.
Webinar Chair and Keynote Speakers: